Prohost Letter #401
SYNOPSIS

PART 1 In this Letter

CONTENTS

Duchenne Muscular Dystrophy (DMD)

FDA Compassionate Approval of Eteplirsen!

PART 2

In The Letter Issue #402

CONTENTS

EYE ON IONIS (IONS)

Antisense Proof of Concept and Feasibility

EYE ON INVIVA (INVA) AND THERAVANCE BIOPHARMA (TBPH)

Sales of The Ellipta Inhalers Started to Pick up Before an expected Boom

Not Losing . . .